Use of Antiretroviral (ARV) Drug Levels in Dried Blood Spots (DBS) to Assess and Manage ART Adherence in South Africa

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 18, 2020

Primary Completion Date

December 15, 2021

Study Completion Date

November 29, 2022

Conditions
Therapeutic Adherence and Compliance
Interventions
BEHAVIORAL

Feedback on DBS Concentrations

The study team will examine the feasibility and acceptability of a feedback system based on DBS concentration amounts.

Trial Locations (2)

7750

Gugulethu Clinic, Cape Town

10032

1051 Riverside Drive, New York

All Listed Sponsors
collaborator

Research Foundation for Mental Hygiene, Inc.

OTHER

collaborator

Desmond Tutu HIV Foundation

OTHER

collaborator

University of Cape Town

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT04333498 - Use of Antiretroviral (ARV) Drug Levels in Dried Blood Spots (DBS) to Assess and Manage ART Adherence in South Africa | Biotech Hunter | Biotech Hunter